NACI has not yet issued advice on how the Janssen vaccine should be integrated into public health programs in Canada. It is authorized, of course, in the country, but the committee has been deliberating and has been waiting as more information comes forward. Obviously, we have seen the evolving situation in the U.S.
The committee has been discussing the Janssen vaccine and is expecting to provide advice before doses arrive in the country. They are moving to provide us advice this month. That's the expectation from the committee.
We don't know at this time what the conclusions of their deliberations will be and where they will see to fit Janssen into the public health programs recommended to provinces and territories.